Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B

Chia Yun Wu, Liang Tsai Hsiao, Tzeon Jye Chiou, Jyh Pyng Gau, Jin Hwang Liu, Yuan Bin Yu, Yi Tsui Wu, Chia Jen Liu, Yu Chung Huang, Man Hsin Hung, Po Min Chen, Yi Hsiang Huang, Cheng Hwai Tzeng

研究成果: 雜誌貢獻 › 文章 › 同行評審

10 引文 斯高帕斯（Scopus）

指紋

深入研究「Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B」主題。共同形成了獨特的指紋。

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science